The Lancet: November 22, 2012

from Listen to The Lancet · host The Lancet

David Cunningham from the Royal Marsden Hospital in London assesses the potential of regorafenib in the treatment of colorectal cancer and gastrointestinal stromal tumours.

Episode metadata supplied by the publisher feed · Published Nov 22, 2012

Embed this episode

Attribution link and audio player

NOW PLAYING

The Lancet: November 22, 2012

0:00 10:05

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet?

This episode is 10 minutes long.

When was this Listen to The Lancet episode published?

This episode was published on November 22, 2012.

Can I download this Listen to The Lancet episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!